Trademark applications and grants for Esteve Pharmaceuticals S A. Esteve Pharmaceuticals S A has 18 trademark applications. The latest application filed is for "ACRYSTA"
Patent Application | Date |
---|---|
METHODS FOR THE MANUFACTURE OF RECOMBINANT VIRAL VECTORS 20220186255 - 17/598503 GODIA-CASABLANCAS; Francesc ;   et al. | 2022-06-16 |
RECOMBINANT VECTORS FOR THE LONG TERM TREATMENT OF MUCCHOPOLYSACHARIDOSIS 20220042043 - 17/413973 BOSCH-TUBERT; Maria-Fatima ;   et al. | 2022-02-10 |
ANIMAL MODEL OF MUCOPOLYSACCHARIDOSES TYPE IVA 20220007621 - 17/293653 BOSCH-TUBERT; Maria-Fatima ;   et al. | 2022-01-13 |
NEW TETRAHYDROPYRIMIDODIAZEPIN AND TETRAHYDROPYRIDODIAZEPIN COMPOUNDS FOR TREATING PAIN AND PAIN RELATED CONDITIONS 20210395254 - 17/289761 CUEVAS-CORDOBES; Felix ;   et al. | 2021-12-23 |
NEW ALKOXYAMINOPYRIDINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS 20210395249 - 17/288934 ALMANSA-ROSALES; Carmen ;   et al. | 2021-12-23 |
NCAGE Code | 0637B | ESTEVE PHARMACEUTICALS SA |
CAGE Code | 0637B | ESTEVE PHARMACEUTICALS SA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.